Early Development Bioconjugate Services

Bioconjugate therapeutics are a fast-growing class of drugs for a wide spectrum of diseases. From our experts, you can get solutions that are specifically tailored to your therapeutic needs and can streamline your process development and manufacturing.
Contact the experts

Our locations

Location where this service is provided

Visp, Switzerland

Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development and manufacturing.

Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our Ibex® Solutions pioneering services offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.

Learn more

Related Insights